Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry

<p>Abstract</p> <p>Background</p> <p>Sulfatides (ST) are a category of sulfated galactosylceramides (GalCer) that are elevated in many types of cancer including, possibly, ovarian cancer. Previous evidence for elevation of ST in ovarian cancer was based on a colorimetri...

Full description

Bibliographic Details
Main Authors: McDonald John F, Walker L, Matyunina Lilya V, Bowen Nathan J, Wang Elaine, Shaner Rebecca, Momin Amin, Chen Yanfeng, Liu Ying, Sullards M, Merrill Alfred H
Format: Article
Language:English
Published: BMC 2010-07-01
Series:Molecular Cancer
Online Access:http://www.molecular-cancer.com/content/9/1/186
id doaj-e04c83daea5d40d3ab76e7042880f1fc
record_format Article
spelling doaj-e04c83daea5d40d3ab76e7042880f1fc2020-11-25T00:27:52ZengBMCMolecular Cancer1476-45982010-07-019118610.1186/1476-4598-9-186Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometryMcDonald John FWalker LMatyunina Lilya VBowen Nathan JWang ElaineShaner RebeccaMomin AminChen YanfengLiu YingSullards MMerrill Alfred H<p>Abstract</p> <p>Background</p> <p>Sulfatides (ST) are a category of sulfated galactosylceramides (GalCer) that are elevated in many types of cancer including, possibly, ovarian cancer. Previous evidence for elevation of ST in ovarian cancer was based on a colorimetric reagent that does not provide structural details and can also react with other lipids. Therefore, this study utilized mass spectrometry for a structure-specific and quantitative analysis of the types, amounts, and tissue localization of ST in ovarian cancer, and combined these findings with analysis of mRNAs for the relevant enzymes of ST metabolism to explore possible mechanisms.</p> <p>Results</p> <p>Analysis of 12 ovarian tissues graded as histologically normal or having epithelial ovarian tumors by liquid chromatography electrospray ionization-tandem mass spectrometry (LC ESI-MS/MS) established that most tumor-bearing tissues have higher amounts of ST. Because ovarian cancer tissues are comprised of many different cell types, histological tissue slices were analyzed by matrix-assisted laser desorption ionization-tissue-imaging MS (MALDI-TIMS). The regions where ST were detected by MALDI-TIMS overlapped with the ovarian epithelial carcinoma as identified by H & E staining and histological scoring. Furthermore, the structures for the most prevalent species observed via MALDI-TIMS (d18:1/C16:0-, d18:1/C24:1- and d18:1/C24:0-ST) were confirmed by MALDI-TIMS/MS, whereas, a neighboring ion(<it>m/z </it>885.6) that was not tumor specific was identified as a phosphatidylinositol. Microarray analysis of mRNAs collected using laser capture microdissection revealed that expression of <it>GalCer synthase </it>and <it>Gal3ST1 </it>(3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) were approximately 11- and 3.5-fold higher, respectively, in the ovarian epithelial carcinoma cells versus normal ovarian stromal tissue, and they were 5- and 2.3-fold higher in comparison with normal surface ovarian epithelial cells, which is a likely explanation for the higher ST.</p> <p>Conclusions</p> <p>This study combined transcriptomic and lipidomic approaches to establish that sulfatides are elevated in ovarian cancer and should be evaluated further as factors that might be important in ovarian cancer biology and, possibly, as biomarkers.</p> http://www.molecular-cancer.com/content/9/1/186
collection DOAJ
language English
format Article
sources DOAJ
author McDonald John F
Walker L
Matyunina Lilya V
Bowen Nathan J
Wang Elaine
Shaner Rebecca
Momin Amin
Chen Yanfeng
Liu Ying
Sullards M
Merrill Alfred H
spellingShingle McDonald John F
Walker L
Matyunina Lilya V
Bowen Nathan J
Wang Elaine
Shaner Rebecca
Momin Amin
Chen Yanfeng
Liu Ying
Sullards M
Merrill Alfred H
Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry
Molecular Cancer
author_facet McDonald John F
Walker L
Matyunina Lilya V
Bowen Nathan J
Wang Elaine
Shaner Rebecca
Momin Amin
Chen Yanfeng
Liu Ying
Sullards M
Merrill Alfred H
author_sort McDonald John F
title Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry
title_short Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry
title_full Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry
title_fullStr Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry
title_full_unstemmed Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry
title_sort elevation of sulfatides in ovarian cancer: an integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry
publisher BMC
series Molecular Cancer
issn 1476-4598
publishDate 2010-07-01
description <p>Abstract</p> <p>Background</p> <p>Sulfatides (ST) are a category of sulfated galactosylceramides (GalCer) that are elevated in many types of cancer including, possibly, ovarian cancer. Previous evidence for elevation of ST in ovarian cancer was based on a colorimetric reagent that does not provide structural details and can also react with other lipids. Therefore, this study utilized mass spectrometry for a structure-specific and quantitative analysis of the types, amounts, and tissue localization of ST in ovarian cancer, and combined these findings with analysis of mRNAs for the relevant enzymes of ST metabolism to explore possible mechanisms.</p> <p>Results</p> <p>Analysis of 12 ovarian tissues graded as histologically normal or having epithelial ovarian tumors by liquid chromatography electrospray ionization-tandem mass spectrometry (LC ESI-MS/MS) established that most tumor-bearing tissues have higher amounts of ST. Because ovarian cancer tissues are comprised of many different cell types, histological tissue slices were analyzed by matrix-assisted laser desorption ionization-tissue-imaging MS (MALDI-TIMS). The regions where ST were detected by MALDI-TIMS overlapped with the ovarian epithelial carcinoma as identified by H & E staining and histological scoring. Furthermore, the structures for the most prevalent species observed via MALDI-TIMS (d18:1/C16:0-, d18:1/C24:1- and d18:1/C24:0-ST) were confirmed by MALDI-TIMS/MS, whereas, a neighboring ion(<it>m/z </it>885.6) that was not tumor specific was identified as a phosphatidylinositol. Microarray analysis of mRNAs collected using laser capture microdissection revealed that expression of <it>GalCer synthase </it>and <it>Gal3ST1 </it>(3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) were approximately 11- and 3.5-fold higher, respectively, in the ovarian epithelial carcinoma cells versus normal ovarian stromal tissue, and they were 5- and 2.3-fold higher in comparison with normal surface ovarian epithelial cells, which is a likely explanation for the higher ST.</p> <p>Conclusions</p> <p>This study combined transcriptomic and lipidomic approaches to establish that sulfatides are elevated in ovarian cancer and should be evaluated further as factors that might be important in ovarian cancer biology and, possibly, as biomarkers.</p>
url http://www.molecular-cancer.com/content/9/1/186
work_keys_str_mv AT mcdonaldjohnf elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry
AT walkerl elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry
AT matyuninalilyav elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry
AT bowennathanj elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry
AT wangelaine elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry
AT shanerrebecca elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry
AT mominamin elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry
AT chenyanfeng elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry
AT liuying elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry
AT sullardsm elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry
AT merrillalfredh elevationofsulfatidesinovariancanceranintegratedtranscriptomicandlipidomicanalysisincludingtissueimagingmassspectrometry
_version_ 1725338053158895616